Abstract
It has long been suspected that there is a strong interaction between sex hormones and the immune system. Several observations support this concept such as the dimorphic nature of the two genders, alterations in the immune response after gonadectomy or sex steroid hormone treatment, modification of the immune response during pregnancy, and the identification of steroid hormone receptors in cells of the immune system support this concept. Numerous in vitro and in vivo experiments have demonstrated that sex hormones affect and modify the actions of cells of the immune system. In addition, considerable evidence has accumulated suggesting that the interaction between estrogen and cells of the immune system can have non-immune regulatory effects. Thus, the role of estrogen in prevention of bone loss is mediated by mechanisms involving the inhibition of proinflammatory cytokines by bone marrow cells [1 – 3].Moreover, disorders frequently affecting women after menopause, such as cardiovascular disease, osteoporosis, or neurodegenerative disorders, can be ascribed to the loss of sex hormone-dependent regulation of physiological functions, as well as to a modification of the non-immune functions of resident immune cells [4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jilka R, Hangok G, Girasole G, et al. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 1992; 257:88–91.
Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 1994; 94:2397–406.
Kimble RB, Kitazawa R, Vannice JL, Pacifici R. Persistent bone-sparing effect of interleukin-1 receptor antagonist: A hypothesis on the role of IL-1 in ovarieetomy-induced bone loss. Calcif Tissue Int 1994; 55:260–65.
Mor G, Naftolin F. Oestrogen, menopause and the immune system. JBMS 1998; 4:4–8.
van der Meer JW, Vogels MT, Netea MG, Kullberg BJ. Proinflammatory cytokines and treatment of disease. Ann N Y Acad Sci 1998; 856:243–51.
van Deuren M, Dofferhoff AS, van der Meer JW. Cytokines and the response to infection. J Pathol 1992;168:349–56.
Mor G, Klinman D, Shapiro S, et al. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol 1995; 155:2039–46.
Weetman AP. The immunology of pregnancy. Thyroid 1999; 9:643–46.
Ahmed S, Penhale W, TalalN., Sex hormones, immune response and autoimmune disease. Am J Path 1985;121:531–51.
Schuurs A, Verheul H. Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990;35:157–72.
Verheul H, Tittes E, Kelder J, Schuurs A. Effects of steroids with different endocrine profiles on the development, morphology and function of the bursa of Fabricious in chickens. J Steroid Bioch 1986; 25: 665–75.
Ben-Hur H, Mor G, Insler V, et al. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. AJRI 1995; 34:363–69.
Erben RG, Raith S, Eberle J, Stangassinger M. Ovariectomy augments B lymphopoiesis and eneration of monocyte-macrophage precursors in rat bone marrow. Am J Physiol 1998; 274:E476–83.
Talal N. Autoimmunity and sex revisited.Clin Immunol Immunopathol 1989;53:355–57.
Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT, Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13:217–26.
Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci 1998; 840: 45–50.
Whitacre CC, Reingold SC, O’Looney PA. A gender gap in autoimmunity. Science 1999; 283:1277–78.
Olsen N, Kovacs W. Gonadal steroids and immunity. Endocrine Rev 1996; 17:369–84.
Polan M, Daniele A, Kuo A. Gonodal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fert Steril 1988; 49:964–68.
Polan ML, Loukides J, Nelson P, et al. Progesterone and estradiol modulate interleukin-1-beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin EndocMetab 1989; 69:1200–6.
Lahita RG, Bradlow HL. Klinefelter’s syndrome: Hormone metabolism in hypogonadal males with systemic lupus erythematosus. J Rheumatol 1987; 14(Suppl. 13): 154–57.
Lahita RG, Bradlow HL, Ginzler E, Pang S, New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987; 30:241–48.
Wilder RL, Elenkov IJ. Hormonal regulation of tumor necrosis factor-alpha, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus? Ann NY Acad Sci 1999; 876:14–31.
Evans MJ, MacLaughlin S, Marvin RD, Abdou NI. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures. Clin Immunol Immunopathol 1997; 82:258–62.
Vegeto E, Pollio G, Pellicciari C, Maggi A. Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-alpha-induced apoptosis. FASEB J 1999; 13:793–803.
Poser S, Kurtzke JF, Poser W, Schlaf G. Survival in multiple sclerosis. J Clin Epidemiol 1989; 42:159–68.
Adashi E. The potential relevance of cytokines to ovarian physiology:The emerging role of resident ovarian cells of the white blood cell series. End Rev 1990; 11:454–63.
Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 1991; 78:688–99.
Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-gamma promoter. J Immunol 1991; 146:4362–67.
Hu S-K, Mitcho Y, Rath N. Effect of estradiol on Interleukin 1 synthesis by macrophages. Int J Immunopharmac 1988; 10:247–52.
Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid proteinspecific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997; 158:446–51.
Jasper M, Norman RJ. Immunoactive interleukin-1 beta and tumour necrosis factor-alpha in thecal, stromal and granulosa cell cultures from normal and polycystic ovaries. Hum Reprod 1995; 10:1352–54.
Bonello N, McKie K, Jasper M, et al. Inhibition of nitric oxide: Effects on interleukin-1 beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol Reprod 1996; 54:436–45.
Kruessel JS, Huang HY, Wen Y, Kloodt AR, Bielfeld P, Polan ML. Different pattern of interleukin-1 beta-(IL-l beta), interleukin-1 receptor antagonist-(IL-Ira) and interleukin-1 receptor type I- (IL-1R tI) mRNA-expression in single preimplantation mouse embryos at various developmental stages. J Reprod Immunol 1997; 34:103–20.
Tabibzadeh S. Human endometrium: An active site of cytokine production and action. End Rev 1991; 12:272–90.
Dayan M, Zinger H, Kalush F, et al. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunol 1997; 90:101–8.
Elenkov IJ, Hoffman J, Wilder RL. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol Med Today 1997; 3:379–83.
Chaouat G, Cayol V, Mairovitz V, Dubanchet S. Localization of the Th2 cytokines IL-3, IL-4, IL-10 at the fetomaternal interface during human and murine pregnancy and lack of requirement for Fas/Fas ligand interaction for a successful allogeneic pregnancy. Am J Reprod Immunol 1999; 42:1–13.
Ostensen M. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann NY Acad Sci 1999; 876:131–43; discussion 144.
Evans R. The steroid and thyroid hormone receptor superfamily. Science 1988; 240:889–95.
Carbone A, Piantelli M, Musiani P, et al. Estrogen binding sites in peripheral blood monuclear cells and thymocytes from 2 myasthenia bravis patients. J Clin Lab Immunol 1986; 21:87–91.
Mor G, Zaltsman Y, Barnard G, Ben-Hur H,Kohen F. Evidence for the presence of estrogen receptor in monocytes. Endoc J 1993; 1:387–95.
Cohen J, Danel L, Gordier G, Saez S, Revillard J. Sex steroid receptors in peripheral T cells; abscence of androgen receptors and restriction of estrogen receptors to OKT 8 positive cells. J Immun 1983; 131:2767–71.
Zaltsman Y, Mor G, Globerson A, Thole H, Kohen F. Expression of estrogen receptors in thymocytes. Endoc J 1993; 1:211–17.
Gulshan S, McCruden A, Stimson W. Oestrogen receptors in macrophages. Scand J Immunol 1990; 31:691–97.
Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93:5925–30.
Kuiper GGJM, Gustafsson J-A. The novel estrogen receptor-p subtype: Potential role in the celland promoter-specific actions of estrogens and anti-estrogens. FEBS Letters 1996; 410:87–90.
Mor G, Nilsen J, Horvath T, et al. Estrogen and microglia: A regulatory system that affects the brain. J Neurobio 1999; 40:484–96.
Albrecht AE, Hartmann BW, Scholten C, Huber JC, Kalinowska W, Zielinski CC. Effect of estrogen replacement therapy on natural killer cell activity in postmenopausal women. Maturitas 1996; 25:217–22.
Lahita RG. Emerging concepts for sexual predilection in the disease systemic lupus erythematosus. Ann NY Acad Sci 1999; 876:64–69; discussion 69–70.
Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11:352–56.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mor, G. (2002). Sex Hormones and the Immune System: Implications for Menopause and Autoimmunity. In: Lobo, R.A., Crosignani, P.G., Paoletti, R., Bruschi, F. (eds) Women’s Health and Menopause. Medical Science Symposia Series, vol 17. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1061-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1061-1_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5375-1
Online ISBN: 978-1-4615-1061-1
eBook Packages: Springer Book Archive